phenyl acetate has been researched along with alpha-Galactosidase A Deficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elliott, S; Gelb, MH; Reeber, SL; Scott, CR; Spáčil, Z; Tureček, F | 1 |
| Beck, M; Birklein, F; Kim, KS; Krummenauer, F; Kutschke, G; Mengel, E; Ries, M | 1 |
1 trial(s) available for phenyl acetate and alpha-Galactosidase A Deficiency
| Article | Year |
|---|---|
Use of gabapentin to reduce chronic neuropathic pain in Fabry disease.
Topics: Acetates; Adolescent; Adult; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Fabry Disease; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Neuralgia; Pain Measurement; Treatment Outcome | 2003 |
1 other study(ies) available for phenyl acetate and alpha-Galactosidase A Deficiency
| Article | Year |
|---|---|
Comparative triplex tandem mass spectrometry assays of lysosomal enzyme activities in dried blood spots using fast liquid chromatography: application to newborn screening of Pompe, Fabry, and Hurler diseases.
Topics: Acetates; Acetonitriles; Blood Specimen Collection; Chemical Fractionation; Chromatography, High Pressure Liquid; Enzymes; Fabry Disease; Flow Injection Analysis; Glycogen Storage Disease Type II; Humans; Infant, Newborn; Lysosomes; Mucopolysaccharidosis I; Neonatal Screening; Tandem Mass Spectrometry | 2011 |